Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go:
Expired
investment:
Withheld
Aiming to prevent further deterioration and leakage of water and sewerage pipes, Aqualiner has developed their Melt in Place Pipe (MIPP). This patented technology consists of a sock insertion, which when heated, expands and melts onto the inner pipe and forms a solid glass-reinforced thermoplastic layer. This process can increase the longevity of existing pipes and is the only product of this type to be approved to be safe-for-use in drinking water pipes. The UK has more than 251,000 miles of water pipes, where almost 75,000 miles of pipes are classed as damaged.
Aqualiner firstly plans to sell the initial equipment in return for a small profit margin, but the materials and consumables used in the process will be sold to the licensed contractor directly as a second income stream. The third source of revenue is derived from fees charged to International territorial licensors for any Aqualiner sales.
The product has been developed with support from Anglian Water, Severn Trent Water and Yorkshire Water and is approved to be installed in US drinking water pipes.
days to go:
Expired
investment:
£642,471
Arca is helping to build the market for property market risk transfer by dealing in derivatives for domestic and commercial properties. Nick Ruddell has held senior roles for the last 30 years with banks and big interdealer brokers.
days to go:
Expired
investment:
£676,500
Arca have introduced new tools for property risk management and created a marketplace to trade portfolio risks to match buyers and sellers of financial products connected to the performance of real estate. They are opening up the concept of short term property market risk management for property portfolio managers.
days to go:
Expired
investment:
£575,000
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go:
Expired
investment:
£1,146,318
A personal fitness app that aims to provide affordable and accessible training on demand. Auro offers classes for specific needs via an audio coach; from increasing stamina, to losing weight. Each class includes a motivational trainer with a dedicated playlist. The company also utilises artificial intelligence to personalise workout programmes for each user and has filed a patent for this technology.
Auro’s app has already received more than 10k downloads and is backed by top investors, such as the founders of LoveFilm, Zoopla and Passion Capital. The company is raising funds to scale the business further in the UK and expand into Europe.
days to go:
Expired
investment:
£262,230
We are a property Market Place matching Buyers and Sellers, Landlords and Tenants without the use of estate agents. The online portal will dramatically reduce the fees that sellers and landlords pay agents to find buyers and tenants for their properties
days to go:
Expired
investment:
Withheld
Belluscura aims at attending millions of people worldwide who are suffering from chronic lung diseases by providing them with the X-PLOR, portable, a lightweight, oxygen delivery device. It has developed it mainly to improve both the mobility and the life quality of the patients suffering from Chronic Obstructive Pulmonary Disease globally. It also has an exclusive license to a patented portable oxygen concentrator, the X-PLOR, that supplies 96% pure oxygen to patients 24/7. It's X-PLOR weights only 1.4kg and is 33% lighter, and provides 37% more oxygen per kg than its leading opponents. As smoke, pollution, and lives increase, the oxygen market will continue to grow from £1.1bn to £1.9bn by 2024. So, according to its market research, a 3% market share within 3 years could generate £46m in sales. With the funds raised, it is planning to extend its proprietary oxygen platform technology into other multi £bn markets such as wound care and sleep. Furthermore, it has filed patents on a next-generation portable artificial lung.
days to go:
Expired
investment:
£543,670
BeneTalk is an innovative digital therapeutic solution, providing on-demand support to individuals who stutter and their families, aiming to enhance their quality of life and confidence. Stuttering affects millions globally, and with limited specialized therapy options, BeneTalk addresses accessibility challenges by offering timely assistance, aiming to mitigate the higher risk of low self-esteem and mental health issues faced by individuals who stutter and their families.
days to go:
Expired
investment:
£173,123
Offering coached performance training through an immersive class experience in a premium boutique gym environment. Binary Fitness are in the process of building a multi-purpose training hall and two spaces for classes that will deliver CrossFit courses, as well as yoga and strength sessions.
Binary Fitness currently has 200 members that pay a monthly membership averaging £160 and has YoY net membership growth of 34% up to September 2018. In the past 3 months, the company has achieved sales averaging £30k per month. Revenue is generated via tiered membership subscriptions, personal training, a café and brand merchandise.
days to go:
Expired
investment:
£707,630
